These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 12175454)
1. Effect of prenatal administration of haloperidol, risperidone, quetiapine and olanzapine on spatial learning and retention in adult rats. Rosengarten H; Quartermain D Pharmacol Biochem Behav; 2002 Jun; 72(3):575-9. PubMed ID: 12175454 [TBL] [Abstract][Full Text] [Related]
2. Long-term effects of olanzapine, risperidone, and quetiapine on dopamine receptor types in regions of rat brain: implications for antipsychotic drug treatment. Tarazi FI; Zhang K; Baldessarini RJ J Pharmacol Exp Ther; 2001 May; 297(2):711-7. PubMed ID: 11303062 [TBL] [Abstract][Full Text] [Related]
3. Comparison of the effects of antipsychotics on a delayed radial maze task in the rat. Wolff MC; Leander JD Psychopharmacology (Berl); 2003 Aug; 168(4):410-6. PubMed ID: 12709778 [TBL] [Abstract][Full Text] [Related]
4. The dose-dependent effect of chronic administration of haloperidol, risperidone, and quetiapine on sexual behavior in the male rat. Zhang XR; Zhang ZJ; Jenkins TA; Cheng WR; Reynolds GP J Sex Med; 2011 Dec; 8(12):3345-53. PubMed ID: 20233290 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials. Leucht S; Pitschel-Walz G; Abraham D; Kissling W Schizophr Res; 1999 Jan; 35(1):51-68. PubMed ID: 9988841 [TBL] [Abstract][Full Text] [Related]
6. Combined treatment of quetiapine with haloperidol in animal models of antipsychotic effect and extrapyramidal side effects: comparison with risperidone and chlorpromazine. Tada M; Shirakawa K; Matsuoka N; Mutoh S Psychopharmacology (Berl); 2004 Oct; 176(1):94-100. PubMed ID: 15083255 [TBL] [Abstract][Full Text] [Related]
7. Long-term antipsychotic monotherapy for schizophrenia: disease burden and comparative outcomes for patients treated with olanzapine, quetiapine, risperidone, or haloperidol monotherapy in a pan-continental observational study. Dossenbach M; Pecenak J; Szulc A; Irimia V; Anders M; Logozar-Perkovic D; Peciukaitiene D; Kotler M; Smulevich AB; West TM; Lowry AJ; Treuer T J Clin Psychiatry; 2008 Dec; 69(12):1901-15. PubMed ID: 19012820 [TBL] [Abstract][Full Text] [Related]
8. Long-term effects of olanzapine, risperidone, and quetiapine on ionotropic glutamate receptor types: implications for antipsychotic drug treatment. Tarazi FI; Baldessarini RJ; Kula NS; Zhang K J Pharmacol Exp Ther; 2003 Sep; 306(3):1145-51. PubMed ID: 12829726 [TBL] [Abstract][Full Text] [Related]
9. Effects of antipsychotic drugs on operant responding after acute and repeated administration. Varvel SA; Vann RE; Wise LE; Philibin SD; Porter JH Psychopharmacology (Berl); 2002 Mar; 160(2):182-91. PubMed ID: 11875636 [TBL] [Abstract][Full Text] [Related]
11. Effectiveness of antipsychotic treatments for schizophrenia: interim 6-month analysis from a prospective observational study (IC-SOHO) comparing olanzapine, quetiapine, risperidone, and haloperidol. Dossenbach M; Erol A; el Mahfoud Kessaci M; Shaheen MO; Sunbol MM; Boland J; Hodge A; O'Halloran RA; Bitter I; J Clin Psychiatry; 2004 Mar; 65(3):312-21. PubMed ID: 15096069 [TBL] [Abstract][Full Text] [Related]
12. How effective is it to sequentially switch among Olanzapine, Quetiapine and Risperidone?--A randomized, open-label study of algorithm-based antipsychotic treatment to patients with symptomatic schizophrenia in the real-world clinical setting. Suzuki T; Uchida H; Watanabe K; Nomura K; Takeuchi H; Tomita M; Tsunoda K; Nio S; Den R; Manki H; Tanabe A; Yagi G; Kashima H Psychopharmacology (Berl); 2007 Dec; 195(2):285-95. PubMed ID: 17701027 [TBL] [Abstract][Full Text] [Related]
13. Atypical antipsychotics and dopamine D(1) receptor agonism: an in vivo experimental study using core temperature measurements in the rat. Oerther S; Ahlenius S J Pharmacol Exp Ther; 2000 Feb; 292(2):731-6. PubMed ID: 10640312 [TBL] [Abstract][Full Text] [Related]
14. Long-term effects of olanzapine, risperidone, and quetiapine on serotonin 1A, 2A and 2C receptors in rat forebrain regions. Tarazi FI; Zhang K; Baldessarini RJ Psychopharmacology (Berl); 2002 May; 161(3):263-70. PubMed ID: 12021829 [TBL] [Abstract][Full Text] [Related]
15. Patient characteristics and prescription patterns of atypical antipsychotics among patients with schizophrenia. Ren XS; Kazis LE; Lee AF; Hamed A; Huang YH; Cunningham F; Miller DR J Clin Pharm Ther; 2002 Dec; 27(6):441-51. PubMed ID: 12472984 [TBL] [Abstract][Full Text] [Related]
16. Ziprasidone: a novel antipsychotic agent with a unique human receptor binding profile. Schmidt AW; Lebel LA; Howard HR; Zorn SH Eur J Pharmacol; 2001 Aug; 425(3):197-201. PubMed ID: 11513838 [TBL] [Abstract][Full Text] [Related]
17. Effects of acute and chronic administration of olanzapine in comparison to clozapine and haloperidol on extracellular recordings of substantia nigra reticulata neurons in the rat brain. Timmerman W; Heijmen M; Westerink BH; Bruggeman R; den Boer JA Psychopharmacology (Berl); 1999 Jun; 144(3):286-94. PubMed ID: 10435397 [TBL] [Abstract][Full Text] [Related]
18. D2 and 5-HT2 receptor effects of antipsychotics: bridging basic and clinical findings using PET. Remington G; Kapur S J Clin Psychiatry; 1999; 60 Suppl 10():15-9. PubMed ID: 10340683 [TBL] [Abstract][Full Text] [Related]
19. EEG abnormalities associated with antipsychotics: a comparison of quetiapine, olanzapine, haloperidol and healthy subjects. Amann BL; Pogarell O; Mergl R; Juckel G; Grunze H; Mulert C; Hegerl U Hum Psychopharmacol; 2003 Dec; 18(8):641-6. PubMed ID: 14696024 [TBL] [Abstract][Full Text] [Related]
20. [A naturalistic, observational study of outpatients with schizophrenia: efficacy and safety results after 6 months. The International Schizophrenia Outpatient Health Outcomes study, IC-SOHO]. István S; Agoston T; Tamás T; Zoltán J Neuropsychopharmacol Hung; 2007 Oct; 9(3):115-24. PubMed ID: 18399029 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]